AKR1B1 and diabetes mellitus: Overall, the multifaceted pharmacological properties of ALA, including its antioxidant activity, modulation of endothelial function, and inhibition of aldose reductase, highlight its potential as a promising adjunctive therapy in the comprehensive management of diabetes-related complications, such as neuropathy and retinopathy.